Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 1
1976 3
1978 1
1979 2
1980 1
1981 1
1982 2
1984 1
1985 3
1987 2
1989 2
1991 1
1993 1
1994 6
1995 3
1996 3
1997 4
1998 4
1999 9
2000 6
2002 4
2003 2
2004 1
2005 4
2006 6
2007 5
2008 8
2009 5
2010 7
2011 15
2012 19
2013 15
2014 22
2015 20
2016 8
2017 13
2018 22
2019 10
2020 13
2021 11
2022 14
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial.
Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators. Teng E, et al. JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375. JAMA Neurol. 2022. PMID: 35696185 Free PMC article. Clinical Trial.
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease.
Ayalon G, Lee SH, Adolfsson O, Foo-Atkins C, Atwal JK, Blendstrup M, Booler H, Bravo J, Brendza R, Brunstein F, Chan R, Chandra P, Couch JA, Datwani A, Demeule B, DiCara D, Erickson R, Ernst JA, Foreman O, He D, Hötzel I, Keeley M, Kwok MCM, Lafrance-Vanasse J, Lin H, Lu Y, Luk W, Manser P, Muhs A, Ngu H, Pfeifer A, Pihlgren M, Rao GK, Scearce-Levie K, Schauer SP, Smith WB, Solanoy H, Teng E, Wildsmith KR, Bumbaca Yadav D, Ying Y, Fuji RN, Kerchner GA. Ayalon G, et al. Among authors: teng e. Sci Transl Med. 2021 May 12;13(593):eabb2639. doi: 10.1126/scitranslmed.abb2639. Sci Transl Med. 2021. PMID: 33980574 Clinical Trial.
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet.
Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R, Sanabria Bohorquez SM, Anania VG, Wildsmith KR, Schauer SP, Lee J, Dolton MJ, Ramakrishnan V, Abramzon D, Teng E; Lauriet investigators. Monteiro C, et al. Among authors: teng e. Neurology. 2023 Oct 3;101(14):e1391-e1401. doi: 10.1212/WNL.0000000000207663. Epub 2023 Aug 29. Neurology. 2023. PMID: 37643887 Free PMC article. Clinical Trial.
Communicating mild cognitive impairment diagnoses with and without amyloid imaging.
Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, Sajjadi SA, Teng E, Karlawish J. Grill JD, et al. Among authors: teng e. Alzheimers Res Ther. 2017 May 4;9(1):35. doi: 10.1186/s13195-017-0261-y. Alzheimers Res Ther. 2017. PMID: 28472970 Free PMC article. Review.
Current issues in the treatment of OC-spectrum conditions.
Wetterneck CT, Teng EJ, Stanley MA. Wetterneck CT, et al. Among authors: teng ej. Bull Menninger Clin. 2010 Spring;74(2):141-66. doi: 10.1521/bumc.2010.74.2.141. Bull Menninger Clin. 2010. PMID: 20545493 Review.
The Moral Injury Symptom Scale-Military Version.
Koenig HG, Ames D, Youssef NA, Oliver JP, Volk F, Teng EJ, Haynes K, Erickson ZD, Arnold I, O'Garo K, Pearce M. Koenig HG, et al. Among authors: teng ej. J Relig Health. 2018 Feb;57(1):249-265. doi: 10.1007/s10943-017-0531-9. J Relig Health. 2018. PMID: 29196962 Clinical Trial.
262 results